全文获取类型
收费全文 | 1269篇 |
免费 | 20篇 |
国内免费 | 3篇 |
专业分类
系统科学 | 36篇 |
丛书文集 | 1篇 |
理论与方法论 | 19篇 |
现状及发展 | 615篇 |
研究方法 | 129篇 |
综合类 | 417篇 |
自然研究 | 75篇 |
出版年
2020年 | 13篇 |
2019年 | 9篇 |
2018年 | 28篇 |
2017年 | 29篇 |
2016年 | 35篇 |
2015年 | 37篇 |
2014年 | 24篇 |
2013年 | 29篇 |
2012年 | 83篇 |
2011年 | 115篇 |
2010年 | 39篇 |
2009年 | 10篇 |
2008年 | 53篇 |
2007年 | 50篇 |
2006年 | 64篇 |
2005年 | 44篇 |
2004年 | 63篇 |
2003年 | 48篇 |
2002年 | 40篇 |
2001年 | 15篇 |
2000年 | 16篇 |
1999年 | 13篇 |
1993年 | 10篇 |
1992年 | 12篇 |
1987年 | 10篇 |
1985年 | 7篇 |
1984年 | 12篇 |
1982年 | 11篇 |
1981年 | 11篇 |
1980年 | 8篇 |
1979年 | 21篇 |
1978年 | 18篇 |
1977年 | 21篇 |
1976年 | 19篇 |
1975年 | 9篇 |
1974年 | 12篇 |
1973年 | 21篇 |
1972年 | 11篇 |
1971年 | 13篇 |
1970年 | 25篇 |
1969年 | 23篇 |
1968年 | 20篇 |
1967年 | 16篇 |
1966年 | 14篇 |
1965年 | 9篇 |
1964年 | 10篇 |
1963年 | 7篇 |
1962年 | 7篇 |
1961年 | 9篇 |
1959年 | 6篇 |
排序方式: 共有1292条查询结果,搜索用时 31 毫秒
991.
Álvaro L. Peña Cantero Estela Roig Ferrer Thais P. Miranda 《Journal of Natural History》2017,51(25-26):1437-1477
Antarctoscyphus is one of the most characteristic genera of Antarctic benthic hydroids, with nine of the 10 known species considered to be endemic to the Antarctic; only Antarctoscyphus elongatus is also present in the sub-Antarctic region of Kerguelen. Accordingly, the genus was considered to have an Antarctic–Kerguelen distribution. Here we present the results of the study of the species of Antarctoscyphus collected from different Antarctic areas and from the Magellan region, during several expeditions under the United States Antarctic Research Program between 1958 and 1986. A scanning electron microscopy survey of all known species of the genus was carried out. Eight of the 10 known species of Antarctoscyphus were found in the collection, with A. spiralis and A. elongatus being the most frequently found species, whereas A. biformis, A. fragilis and A. gruzovi were found only once. The type material of A. biformis was reviewed and re-described. This study represents the second records for A. biformis and A. fragilis. The new records allow updating of the biogeographic knowledge on the distribution of several species: A. mawsoni, so far considered endemic to East Antarctica, and A. asymmetricus, considered endemic to West Antarctica, are here considered to have a Circum-Antarctic distribution. Additionally, A. fragilis, previously considered endemic to the Weddell Sea, is now considered to have a West Antarctic–Patagonian distribution, as it was recorded off the Pacific Magellan region. The records gathered here allow us to change the distribution pattern of the genus from Antarctic–Kerguelen to Pan-Antarctic. The study has allowed us to increase the known bathymetric range for some species, some reaching much deeper waters than previously known. Hence, A. fragilis, A. grandis and A. mawsoni, hitherto considered shelf species, are reported from bathyal bottoms of the continental slope. A general discussion on the bathymetric and geographic distribution of all known species is included.
www.zoobank.org/urn:lsid:zoobank.org:pub:1C7ED3F2-3FF1-4C5C-85BB-FAAF557AC2ED 相似文献
992.
Laura Pellegrini Andrea Wetzel Simone Grannó George Heaton Kirsten Harvey 《Cellular and molecular life sciences : CMLS》2017,74(3):409-434
Cytoskeletal homeostasis is essential for the development, survival and maintenance of an efficient nervous system. Microtubules are highly dynamic polymers important for neuronal growth, morphology, migration and polarity. In cooperation with several classes of binding proteins, microtubules regulate long-distance intracellular cargo trafficking along axons and dendrites. The importance of a delicate interplay between cytoskeletal components is reflected in several human neurodegenerative disorders linked to abnormal microtubule dynamics, including Parkinson’s disease (PD). Mounting evidence now suggests PD pathogenesis might be underlined by early cytoskeletal dysfunction. Advances in genetics have identified PD-associated mutations and variants in genes encoding various proteins affecting microtubule function including the microtubule-associated protein tau. In this review, we highlight the role of microtubules, their major posttranslational modifications and microtubule associated proteins in neuronal function. We then present key evidence on the contribution of microtubule dysfunction to PD. Finally, we discuss how regulation of microtubule dynamics with microtubule-targeting agents and deacetylase inhibitors represents a promising strategy for innovative therapeutic development. 相似文献
993.
994.
Almudena Fuster-Matanzo Jerónimo Jurado-Arjona Stefano Benvegnù Esther García Patricia Martín-Maestro Raquel Gómez-Sintes Félix Hernández Jesús Ávila 《Cellular and molecular life sciences : CMLS》2017,74(6):1153-1163
Glycogen synthase kinase-3β (GSK-3β) is a serine-threonine kinase implicated in multiple processes and signaling pathways. Its dysregulation is associated with different pathological conditions including Alzheimer’s disease (AD). Here we demonstrate how changes in GSK-3β activity and/or levels regulate the production and subsequent secretion of fractalkine, a chemokine involved in the immune response that has been linked to AD and to other different neurological disorders. Treatment of primary cultured neurons with GSK-3β inhibitors such as lithium and AR-A014418 decreased full-length fractalkine in total cell extracts. Opposite effects were observed after neuron transduction with a lentiviral vector overexpressing the kinase. Biotinylation assays showed that those changes mainly affect the plasma membrane-associated form of the protein, an observation that positively correlates with changes in the levels of its soluble form. These effects were confirmed in lithium-treated wild type (wt) mice and in GSK-3β transgenic animals, as well as in brain samples from AD patients, evident as age-dependent (animals) or Braak stage dependent changes (humans) in both the membrane-bound and the soluble forms of the protein. Further immunohistochemical analyses demonstrated how GSK-3β exerts these effects by affecting the trafficking of the chemokine from the Golgi to the plasma membrane, in different and opposite ways when the levels/activity of the kinase are increased or decreased. This work provides for the first time a mechanism linking GSK-3β and fractalkine both in vitro and in vivo, with important implications for neurological disorders and especially for AD, in which levels of this chemokine might be useful as a diagnostic tool. 相似文献
995.
Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson’s disease 总被引:1,自引:1,他引:0
996.
Ikram MA Fornage M Smith AV Seshadri S Schmidt R Debette S Vrooman HA Sigurdsson S Ropele S Taal HR Mook-Kanamori DO Coker LH Longstreth WT Niessen WJ DeStefano AL Beiser A Zijdenbos AP Struchalin M Jack CR Rivadeneira F Uitterlinden AG Knopman DS Hartikainen AL Pennell CE Thiering E Steegers EA Hakonarson H Heinrich J Palmer LJ Jarvelin MR McCarthy MI Grant SF St Pourcain B Timpson NJ Smith GD Sovio U;Early Growth Genetics Consortium Nalls MA Au R Hofman A Gudnason H van der Lugt A Harris TB 《Nature genetics》2012,44(5):539-544
During aging, intracranial volume remains unchanged and represents maximally attained brain size, while various interacting biological phenomena lead to brain volume loss. Consequently, intracranial volume and brain volume in late life reflect different genetic influences. Our genome-wide association study (GWAS) in 8,175 community-dwelling elderly persons did not reveal any associations at genome-wide significance (P < 5 × 10(-8)) for brain volume. In contrast, intracranial volume was significantly associated with two loci: rs4273712 (P = 3.4 × 10(-11)), a known height-associated locus on chromosome 6q22, and rs9915547 (P = 1.5 × 10(-12)), localized to the inversion on chromosome 17q21. We replicated the associations of these loci with intracranial volume in a separate sample of 1,752 elderly persons (P = 1.1 × 10(-3) for 6q22 and 1.2 × 10(-3) for 17q21). Furthermore, we also found suggestive associations of the 17q21 locus with head circumference in 10,768 children (mean age of 14.5 months). Our data identify two loci associated with head size, with the inversion at 17q21 also likely to be involved in attaining maximal brain size. 相似文献
997.
Stein JL Medland SE Vasquez AA Hibar DP Senstad RE Winkler AM Toro R Appel K Bartecek R Bergmann Ø Bernard M Brown AA Cannon DM Chakravarty MM Christoforou A Domin M Grimm O Hollinshead M Holmes AJ Homuth G Hottenga JJ Langan C Lopez LM Hansell NK Hwang KS Kim S Laje G Lee PH Liu X Loth E Lourdusamy A Mattingsdal M Mohnke S Maniega SM Nho K Nugent AC O'Brien C Papmeyer M Pütz B Ramasamy A Rasmussen J Rijpkema M Risacher SL Roddey JC Rose EJ Ryten M Shen L Sprooten E Strengman E Teumer A 《Nature genetics》2012,44(5):552-561
Identifying genetic variants influencing human brain structures may reveal new biological mechanisms underlying cognition and neuropsychiatric illness. The volume of the hippocampus is a biomarker of incipient Alzheimer's disease and is reduced in schizophrenia, major depression and mesial temporal lobe epilepsy. Whereas many brain imaging phenotypes are highly heritable, identifying and replicating genetic influences has been difficult, as small effects and the high costs of magnetic resonance imaging (MRI) have led to underpowered studies. Here we report genome-wide association meta-analyses and replication for mean bilateral hippocampal, total brain and intracranial volumes from a large multinational consortium. The intergenic variant rs7294919 was associated with hippocampal volume (12q24.22; N = 21,151; P = 6.70 × 10(-16)) and the expression levels of the positional candidate gene TESC in brain tissue. Additionally, rs10784502, located within HMGA2, was associated with intracranial volume (12q14.3; N = 15,782; P = 1.12 × 10(-12)). We also identified a suggestive association with total brain volume at rs10494373 within DDR2 (1q23.3; N = 6,500; P = 5.81 × 10(-7)). 相似文献
998.
EL Heinzen KJ Swoboda Y Hitomi F Gurrieri S Nicole B de Vries FD Tiziano B Fontaine NM Walley S Heavin E Panagiotakaki;European Alternating Hemiplegia of Childhood 《Nature genetics》2012,44(9):1030-1034
Alternating hemiplegia of childhood (AHC) is a rare, severe neurodevelopmental syndrome characterized by recurrent hemiplegic episodes and distinct neurological manifestations. AHC is usually a sporadic disorder and has unknown etiology. We used exome sequencing of seven patients with AHC and their unaffected parents to identify de novo nonsynonymous mutations in ATP1A3 in all seven individuals. In a subsequent sequence analysis of ATP1A3 in 98 other patients with AHC, we found that ATP1A3 mutations were likely to be responsible for at least 74% of the cases; we also identified one inherited mutation in a case of familial AHC. Notably, most AHC cases are caused by one of seven recurrent ATP1A3 mutations, one of which was observed in 36 patients. Unlike ATP1A3 mutations that cause rapid-onset dystonia-parkinsonism, AHC-causing mutations in this gene caused consistent reductions in ATPase activity without affecting the level of protein expression. This work identifies de novo ATP1A3 mutations as the primary cause of AHC and offers insight into disease pathophysiology by expanding the spectrum of phenotypes associated with mutations in ATP1A3. 相似文献
999.
1000.
Laurie CC Laurie CA Rice K Doheny KF Zelnick LR McHugh CP Ling H Hetrick KN Pugh EW Amos C Wei Q Wang LE Lee JE Barnes KC Hansel NN Mathias R Daley D Beaty TH Scott AF Ruczinski I Scharpf RB Bierut LJ Hartz SM Landi MT Freedman ND Goldin LR Ginsburg D Li J Desch KC Strom SS Blot WJ Signorello LB Ingles SA Chanock SJ Berndt SI Le Marchand L Henderson BE Monroe KR Heit JA de Andrade M Armasu SM Regnier C Lowe WL Hayes MG Marazita ML Feingold E Murray JC Melbye M Feenstra B Kang JH Wiggs JL 《Nature genetics》2012,44(6):642-650
We detected clonal mosaicism for large chromosomal anomalies (duplications, deletions and uniparental disomy) using SNP microarray data from over 50,000 subjects recruited for genome-wide association studies. This detection method requires a relatively high frequency of cells with the same abnormal karyotype (>5-10%; presumably of clonal origin) in the presence of normal cells. The frequency of detectable clonal mosaicism in peripheral blood is low (<0.5%) from birth until 50 years of age, after which it rapidly rises to 2-3% in the elderly. Many of the mosaic anomalies are characteristic of those found in hematological cancers and identify common deleted regions with genes previously associated with these cancers. Although only 3% of subjects with detectable clonal mosaicism had any record of hematological cancer before DNA sampling, those without a previous diagnosis have an estimated tenfold higher risk of a subsequent hematological cancer (95% confidence interval = 6-18). 相似文献